Moneycontrol Be a Pro
Get App
SENSEX NIFTY
you are here:

Celestial Biolabs Ltd.

BSE Live

Dec 13, 16:00
3.14 -0.16 (-4.85%)
Volume
AVERAGE VOLUME
5-Day
1,649
10-Day
1,425
30-Day
2,819
2,798
  • Prev. Close

    3.30

  • Open Price

    3.25

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 13, 15:40
3.05 -0.10 (-3.17%)
Volume
AVERAGE VOLUME
5-Day
7,158
10-Day
6,916
30-Day
10,224
2,468
  • Prev. Close

    3.15

  • Open Price

    3.15

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Celestial Bio

  • Nov 20, 2019 14:23 Source: NSE

    Celestial Biolabs Limited

    Celestial Biolabs Limited has informed the Exchange regarding Resignation of Mr Hardeep Choudhary as Company Secretary & Compliance Officer of the company w.e.f. November 05, 2019.

  • Aug 09, 2019 15:37 Source: BSE

    Celestial Biolabs - Board Meeting Intimation for Prior Intimation Of The Board Meeting And Audit Committee Meeting To Be
    Held On 14''08.2019 - Un-Audited Financial Results

    Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 this is to intimate you that a meeting of the Board of Directors and Audit Committee of the Company is schedule to be held on 14.08.2019 to consider and take on record the Un-audited financial results of the Company for the quarter / 3 months ended 30.06.2019.

  • Jul 15, 2019 10:34 Source: BSE

    Celestial Biolabs - Statement Of Investor Complaints For The Quarter Ended June 2019

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0000
    Name of the Signatory :- AMIT KUMAR SINGH
    Designation :- Director

  • Jul 12, 2019 12:26 Source: NSE

    Celestial Biolabs Limited

    Significant movement in price has been observed in Celestial Biolabs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Celestial Biolabs Limited has submitted their response.

  • Jul 11, 2019 10:44 Source: BSE

    Celestial Biolabs - Clarification sought from Celestial Biolabs Ltd

    The Exchange has sought clarification from Celestial Biolabs Ltd on July 11, 2019, with reference to increase in Price.The reply is awaited.

  • Jul 03, 2019 14:10 Source: NSE

    Celestial Biolabs Limited

    CELESTIAL: Celestial Biolabs Limited had informed the Exchange regarding Appointment of Mr Hardeep Choudhary as Company Secretary & Compliance Officer of the company w.e.f. Jun 04, 2019. On basis of above the Company was required to clarify following: 1. Whether intimated in 24hrs 2. Brief profile (in case of appointment) The response of the Company is attached.

  • Jul 03, 2019 14:00 Source: BSE

    Celestial Biolabs - Related Party Transaction Disclosure

    Related party transaction disclosure

  • Jul 02, 2019 10:14 Source: NSE

    Celestial Biolabs Limited

    Celestial Biolabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

  • Jul 01, 2019 17:55 Source: BSE

    Celestial Biolabs - Closure of Trading Window

    Intimation of closure of trading window

  • Jun 24, 2019 12:55 Source: NSE

    Celestial Biolabs Limited

    The Exchange has sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -3. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Aug 14, 2019
Remark : Quarterly Results